)
)
Neoleukin Therapeutics Investor Relations Material
Latest events
M&A Announcement
Neoleukin Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Neoleukin Therapeutics Inc
Access all reports
Neoleukin Therapeutics Inc. is a biopharmaceutical company focused on developing immunotherapies using its proprietary de novo protein design technology. The company’s approach involves creating novel proteins to target immune system pathways, with a particular focus on cancer and inflammatory diseases. Neoleukin’s therapies aim to harness and modulate the immune system to treat diseases more effectively. The company is headquartered in Seattle, Washington, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
NLTX
Country
🇺🇸 United States